R.A. Giacobbe

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 313 citations · Full text

Medicinal Chemistry, Biosynthesis, Antimicrobial Drug Discovery +15

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

Thomas F. Durand-Réville, Satenig Guler, Janelle Comita-Prevoir et al. · Nature Microbiology · 2017 · 262 citations

Bacterial Resistance, Antimicrobial Susceptibility, Health Sciences +12

Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii

William F. Penwell, Adam B. Shapiro, R.A. Giacobbe et al. · Antimicrobial Agents and Chemotherapy · 2015 · 235 citations · Full text

Antibacterial Activity, Penicillin-binding Proteins, Sulbactam Antibacterial Activity +20

The Discovery of Australifungin, a Novel Inhibitor of Sphinganine N-Acyltransferase from Sporormiella australis. Producing Organism, Fermentation, Isolation, and Biological Activity.

Suzanne Mandala, Rosemary Thornton, BETH R. FROMMER et al. · The Journal of Antibiotics · 1995 · 188 citations · Full text

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against <i>Candida</i> and <i>Aspergillus</i> Species

Frank C. Odds, Mary Motyl, Roberto Andrade et al. · Journal of Clinical Microbiology · 2004 · 173 citations · Full text

Mycology, Diagnostic Mycology, Antifungal Agent +12